Bet On the Aussie Buck
The Australian dollar is on the rise, which is historically a good sign for commodity prices. Seven Aussie stocks, two ETFs, and one closed-end fund that could pay off big for U.S. investors.
View ArticleRegeneron: The Best Bet in Biotech Stocks
Regeneron has created tools and technologies that speed the drug-discovery process. Why the shares could grow 35% in a year—and continue up from there.
View ArticleByron Wien: What's Ahead for the Markets
At 83, the investing legend and Blackstone strategist is still trotting the globe. What’s next for stocks, bonds, and the economy.
View Article5 Reasons the Stock Market Won't Crash--Yet
With the bull market now more than seven years old, many investors worry that a crash is imminent. Not so. Five reasons stocks still have room to run.
View ArticleWhere Have All the IPOs Gone?
Rising regulatory burdens combined with a surfeit of venture capital are making new stock offerings passé. That’s good for investors.
View Article2016 Midyear Roundtable: 24 Investment Ideas
Stocks like Alphabet, Nike, and Macy’s could shine in the next year. Learning to love Argentina. Mario Gabelli, Jeffrey Gundlach, Meryl Witmer weigh in.
View ArticleThe Best Watches of 2016
We pick the watches you’ll want to own, in eight different categories.
View ArticleBrexit: Is It the Beginning of the End for the EU?
The Brexit vote hammers markets around the globe, and encourages populist parties in Europe to seek similar referendums for their nations. Looking at the impact on Britain, stocks, and currencies.
View ArticleBrexit Selloff Highlights Strength of U.S. Market
U.S. companies depend on domestic customers, which helps to insulate them from problems abroad.
View ArticleWill the Republicans Lose Control of Congress?
The next Congress could go a long way to blunting the impact of either a Clinton or Trump presidency on issues of concern to investors.
View ArticleThe Future of Mutual Funds
As the industry’s growth slows, expect the push toward ever-lower expenses to continue, with only the best stockpickers thriving.
View ArticleShell: The World's Best Oil Stock
Royal Dutch Shell’s makeover could lift the shares more than 20% in a year—even without a rise in oil prices. Plus, a juicy 6.6% yield.
View ArticlePharmacy-Benefit Managers Under Pressure
American Express, Coca-Cola and others team up to try to cut high drug prices. Shares of Express Scripts, CVS, UnitedHealth are at risk.
View ArticleRuchir Sharma: Wall Street's New Global Thinker
The Morgan Stanley macroeconomist sees more woes ahead for China and Russia. The U.S., India, and Germany will prosper.
View ArticleSafe Yields of Up to 5%: Fixed-Income Panel
Our savvy market experts reveal which funds and individual securities maximize income and minimize risk.
View ArticleHillary Rising
Alternative-energy and hospital stocks could prosper under a Clinton administration, while energy and financial shares could take a big hit.
View ArticleClinton, Trump Are Both Wrong About Free Trade
The presidential candidates focus on the trade deficit in goods when they should consider the surplus in services and other benefits of free trade.
View ArticleThe 10 Best Dividend Stocks
Barron’s picks have hefty yields and nice prices. Why JPMorgan Chase, Verizon, Target, and MetLife make the grade.
View ArticleBarron's Survey: Strategists Say Beware the Bear
Stocks could tread water for the rest of the year—or even fall. Wall Street’s top strategists also predict only modest gains in 2017.
View ArticleThe Experts' Guide to Retirement Planning
Enjoying your health and wealth in retirement takes more work than you might think. Our pros look beyond the numbers. What about the kids?
View Article
